Suppr超能文献

复发性慢性绒毛间组织细胞性炎治疗后成功妊娠。

Successful pregnancy following treatment of recurrent chronic histiocytic intervillositis.

作者信息

Vardi Leehe, Paterson Helen, Hung Noelyn Anne

机构信息

Department of Women's Health, Dunedin Public Hospital, Dunedin, New Zealand.

Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

出版信息

BMJ Case Rep. 2017 Jan 10;2017:bcr2016217886. doi: 10.1136/bcr-2016-217886.

Abstract

Chronic histiocytic intervillositis (CHI) is a rare placental lesion associated with adverse obstetric outcomes and high recurrence rate. We report a case of six consecutive pregnancies in one woman, where CHI was detected following an intrauterine death in the fifth pregnancy, after being missed in four earlier losses. The successful sixth pregnancy was treated with a combination of immunosuppressive and antithrombotic agents. While low-molecular-weight heparin (LMWH) and aspirin had been shown to improve pregnancy outcome in recurrent pregnancy loss, there was limited evidence of improved outcome in CHI. It has been suggested that CHI may result from a maternal immunological process and there have been a few reports of the use of corticosteroids because of this possibility, though without convincing evidence of efficacy. We too tried a corticosteroid, in combination with LMWH and aspirin. Comparative histopathological analysis of the placentae supported post-treatment effectiveness of our intervention strategy.

摘要

慢性组织细胞性绒毛间炎(CHI)是一种罕见的胎盘病变,与不良产科结局及高复发率相关。我们报告一例女性连续六次妊娠的病例,该女性在第五次妊娠发生宫内死亡后检测出CHI,而在前四次流产中均未检出。第六次妊娠成功,采用了免疫抑制和抗血栓药物联合治疗。虽然低分子量肝素(LMWH)和阿司匹林已被证明可改善复发性流产的妊娠结局,但在CHI中改善结局的证据有限。有人认为CHI可能源于母体免疫过程,基于这种可能性有一些使用皮质类固醇的报道,不过尚无令人信服的疗效证据。我们也尝试了一种皮质类固醇,联合LMWH和阿司匹林。胎盘的对比组织病理学分析支持了我们干预策略的治疗后有效性。

相似文献

1
Successful pregnancy following treatment of recurrent chronic histiocytic intervillositis.
BMJ Case Rep. 2017 Jan 10;2017:bcr2016217886. doi: 10.1136/bcr-2016-217886.
2
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Autoimmunity. 2015 Feb;48(1):40-5. doi: 10.3109/08916934.2014.939267. Epub 2014 Jul 16.
4
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.
Front Endocrinol (Lausanne). 2022 Jul 22;13:945543. doi: 10.3389/fendo.2022.945543. eCollection 2022.
6
Chronic histiocytic intervillositis with cytomegalovirus placentitis in a case of hydrops fetalis.
Fetal Pediatr Pathol. 2012 Dec;31(6):394-400. doi: 10.3109/15513815.2012.659405. Epub 2012 Mar 23.
8
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
J Obstet Gynaecol Can. 2017 Aug;39(8):676-681. doi: 10.1016/j.jogc.2017.03.089. Epub 2017 Apr 26.
9
An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss.
Am J Reprod Immunol. 2013 Sep;70(3):230-7. doi: 10.1111/aji.12125. Epub 2013 Apr 24.
10
Antagonists of TNFα for recurrent miscarriages: 2 Illustrative cases.
Eur J Obstet Gynecol Reprod Biol. 2019 May;236:263-264. doi: 10.1016/j.ejogrb.2019.02.036. Epub 2019 Mar 6.

引用本文的文献

2
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.
Front Endocrinol (Lausanne). 2022 Jul 22;13:945543. doi: 10.3389/fendo.2022.945543. eCollection 2022.
3
Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.
Front Immunol. 2022 Apr 22;13:825075. doi: 10.3389/fimmu.2022.825075. eCollection 2022.
4
The Missing Role of Prenatal Diagnosis of Chronic Histiocytic Intervillositis in the Management of Growth Restricted Fetuses.
Front Med (Lausanne). 2022 Feb 2;8:809315. doi: 10.3389/fmed.2021.809315. eCollection 2021.
6
Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis.
Front Med (Lausanne). 2021 Oct 18;8:753220. doi: 10.3389/fmed.2021.753220. eCollection 2021.
9
Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.
Front Immunol. 2020 Nov 13;11:531543. doi: 10.3389/fimmu.2020.531543. eCollection 2020.
10
Association between factor V Leiden mutation and recurrent pregnancy loss in the middle east countries: a Newcastle-Ottawa meta-analysis.
Arch Gynecol Obstet. 2020 Aug;302(2):345-354. doi: 10.1007/s00404-020-05610-6. Epub 2020 May 29.

本文引用的文献

1
Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.
Blood. 2015 Apr 2;125(14):2200-5. doi: 10.1182/blood-2014-11-610857. Epub 2015 Jan 30.
2
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Autoimmunity. 2015 Feb;48(1):40-5. doi: 10.3109/08916934.2014.939267. Epub 2014 Jul 16.
4
Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases.
Placenta. 2011 Feb;32(2):140-5. doi: 10.1016/j.placenta.2010.11.021. Epub 2010 Dec 22.
5
Chronic intervillositis of the placenta: a systematic review.
Placenta. 2010 Dec;31(12):1106-10. doi: 10.1016/j.placenta.2010.10.005. Epub 2010 Oct 29.
6
Pathological characteristics of a series of rare chronic histiocytic intervillositis of the placenta.
Placenta. 2010 Dec;31(12):1116-9. doi: 10.1016/j.placenta.2010.09.012. Epub 2010 Oct 13.
7
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
N Engl J Med. 2010 Apr 29;362(17):1586-96. doi: 10.1056/NEJMoa1000641. Epub 2010 Mar 24.
9
Chronic intervillositis of unknown etiology (CIUE): relation between placental lesions and perinatal outcome.
Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):9-13. doi: 10.1016/j.ejogrb.2008.06.012. Epub 2009 Jan 3.
10
Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
Arch Gynecol Obstet. 2008 Jul;278(1):33-8. doi: 10.1007/s00404-007-0527-x. Epub 2007 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验